CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity

Quality management in breast surgery

SG monotherapy demonstrates a high response rate in PT-ineligible patients with mUC who progressed after CPI therapy

Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some MIBC

Nivolumab and salvage nivolumab plus ipilimumab for aRCC

Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous cell carcinoma

HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer

Management of HER2 positive metastatic breast cancer treatment algorithm

Immuno-radiotherapy: rationale and new perspectives for breast cancer patients

Post neoadjuvant management in BRCA mutant breast cancer patients

The 2022 OncoAlert Colloquium Day 6: EONS Sessions